Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class ASSE: 600196

Notice on Convening the 2025 Annual General Meeting, the 2nd A-Share Shareholders' Meeting in 2026, and the 2nd H-Share Shareholders' Meeting in 2026

· Issued by Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A via Shanghai Stock Exchange
Notice on Convening the 2025 Annual General Meeting, the 2nd A-Share Shareholders' Meeting in 2026, and the 2nd H-Share Shareholders' Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis